General MedicationsINJECTIONGeneric

PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE

Standard Dose

37MG/100ML;5GM/100ML;30MG/100ML;119MG/100ML;161MG/100ML;94MG/100ML;138MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 017390 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength INJECTABLE;INJECTION - 37MG/100ML;5GM/100ML;30MG/100ML;119MG/100ML;161MG/100ML;94MG/100ML;138MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2001-08-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 017390 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength INJECTABLE;INJECTION - 37MG/100ML;5GM/100ML;30MG/100ML;119MG/100ML;161MG/100ML;94MG/100ML;138MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2001-08-14 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.